---
title: "STOCKS | Four Companies File for Hong Kong IPOs, Including Transsion and Shijiazhuang Pharmaceutical Innovation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290284788.md"
description: "Four companies filed applications to list in Hong Kong, including native AI technology firm DataStory and biotech company Zhiyi Bio, according to Ming Pao, with Zhiyi Bio applying under Listing Rules Chapter 18A. The applicants also include A-share listed Transsion Holdings (688036.SS), the parent of Tecno, and A-share listed Shijiazhuang Pharmaceutical Innovation, described as a caffeine health food and biopharmaceutical developer."
datetime: "2026-06-19T10:24:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290284788.md)
  - [en](https://longbridge.com/en/news/290284788.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290284788.md)
generator: "portal-rs"
---

# STOCKS | Four Companies File for Hong Kong IPOs, Including Transsion and Shijiazhuang Pharmaceutical Innovation

Four companies filed applications to list in Hong Kong, including native AI technology firm DataStory and biotech company Zhiyi Bio, according to Ming Pao, with Zhiyi Bio applying under Listing Rules Chapter 18A. The applicants also include A-share listed Transsion Holdings (688036.SS), the parent of Tecno, and A-share listed Shijiazhuang Pharmaceutical Innovation (300765.SZ), described as a caffeine health food and biopharmaceutical developer.

### Related Stocks

- [688036.CN](https://longbridge.com/en/quote/688036.CN.md)
- [300765.CN](https://longbridge.com/en/quote/300765.CN.md)

## Related News & Research

- [CSPC says FDA clears RSV vaccine candidate SYS 6057 for US clinical trial](https://longbridge.com/en/news/296903628.md)
- [SHENZHEN TRANSSION: H1 2026 net profit jumped 46.22% year-over-year, with strong growth in emerging markets](https://longbridge.com/en/news/296129146.md)
- [Fit Group expands MediaMarktSaturn tie-up with Tunnelblick caffeine pouches rollout](https://longbridge.com/en/news/296816266.md)
- [Vise Technologies Inc. Takes $743,000 Position in Halozyme Therapeutics, Inc. $HALO](https://longbridge.com/en/news/296763264.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**